In a significant shift, the F.D.A. is set to impose new restrictions on access to Covid vaccines. As the pandemic evolves, this move reflects ongoing assessments of vaccine efficacy and public health needs, sparking debate on balancing safety and accessibility.
The FDA’s recent decision to restrict access to Covid-19 boosters for Americans under 65 marks a significant shift in pandemic policy. As health authorities adjust their approach, the focus turns to the evolving landscape of vaccine strategy and public health.
In a surprising shift, the new vaccine policy under the Trump administration restricts access to COVID-19 shots. This decision raises questions about equity in healthcare access as the nation continues to combat the pandemic’s lingering effects.